Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Thyme Care closes over $125 million in Series E funding, led by Morgan Health, to broaden its impact across the oncology ecosystem.

PRIVATESep 02, 2026•5 days ago

Amount Raised

$125 Million

Round Type

Series E

NashvilleHealth Care

Investors

A16z Bio + HealthTown Hall VenturesFrist Cressey VenturesConcord Health PartnersForesite CapitalHealth Quest CapitalAlley CorpCvs Health VenturesHumanaMorgan Health

Description

Thyme Care announced a new Series E financing round of over $125 million, led by Morgan Health, with participation from several strategic healthcare investors. The financing aims to enhance their oncology services available to over 10.5 million people across the U.S. Thyme Care's innovative care model seeks to improve cancer care while reducing costs. The company is profitable and positioned for significant growth.

Company Information

Company

Thyme Care

Location

10 Lea Avenue, Suite 760

Nashville, Tennessee, United States

About

Thyme Care is the leading value-based care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers, and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care's approach combines a technology-enabled Care Team and seamless integration with more than 800 oncologists in Thyme Care Oncology Partners, creating a hybrid collaborative care model that guides and supports the entire patient journey. Thyme Care empowers oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. Thyme Care is a founding member of CancerX, and is backed by leading investors.

Don't miss Thyme Care's next move

Get an email the moment Thyme Care raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
2 contacts
Verified contactsRobin S., Director
Predictive Intelligence
Strategic

ML-powered predictions for Thyme Care's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Thyme Care raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.